Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Which rewards card is better for travel? Explore options to maximize your travel benefits and choose the right card for you.
22,786 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Global markets brace for potential price pressures as El Niño-linked commodity risks rise. This report outlines actio...
U.S. equities drift as tariff uncertainty lingers, with the S&P 500 and SPY easing while investors await policy clari...
Ben Chester navigated a path from crushing debt renting to a thriving landlord with eight properties, three short-ter...
When a fintech stalwart like Fiserv experiences a pullback, it can ripple through the broader market. This guide expl...
As inflation remains stubborn, Bank of America nudges its rate outlook higher, forecasting three quarter-point Fed hi...
Take control of your money with the right tools. This guide breaks down the best tools for personal financial plannin...
Choosing between VEA and NZAC boils down to your priority: broad diversification in developed markets or a climate-al...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
NVIDIA's Jensen Huang just signaled a major pivot that could reshape the PC landscape. This article breaks down the i...
A routine trade-in can turn risky when trust is exploited. This article explains how a trusted cellphone clerk handle...
Geopolitical headlines can shake your wallet. Learn how a 5-day pause in planned strikes could ripple through energy ...